Issue 67, 2021

A light-activatable photosensitizer for photodynamic therapy based on a diarylethene derivative

Abstract

Herein, a light-activatable photosensitizer based on a diarylethene derivative, DAE-TPE, was developed for photodynamic therapy. Upon UV exposure, the “opened” form (OF) of DAE-TPE NPs was converted to the “closed” form (CF), and photosensitization was activated. The CF of DAE-TPE NPs exhibited sufficient photodynamic therapy effects upon HeLa cells.

Graphical abstract: A light-activatable photosensitizer for photodynamic therapy based on a diarylethene derivative

Supplementary files

Article information

Article type
Communication
Submitted
20 Apr 2021
Accepted
12 Jul 2021
First published
15 Jul 2021

Chem. Commun., 2021,57, 8320-8323

A light-activatable photosensitizer for photodynamic therapy based on a diarylethene derivative

J. Zhang, R. Zhang, K. Liu, Y. Li, X. Wang, X. Xie, X. Jiao and B. Tang, Chem. Commun., 2021, 57, 8320 DOI: 10.1039/D1CC02102H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements